Varda Space Industries, a pioneering company in the field of space manufacturing, has successfully completed a $90 million Series B funding round. This significant financial milestone follows the successful conclusion of Varda's first mission, which demonstrated the feasibility of manufacturing pharmaceuticals in microgravity and safely returning them to Earth. The mission involved the launch and reentry of the first-ever commercial spacecraft to land on US soil. The company, which had previously raised a total capital of $145 million, aims to leverage this latest funding to transition from demonstration missions to serving its diverse clientele, including publicly traded pharmaceutical companies and government customers. Varda's innovative approach to manufacturing in space, particularly pharmaceuticals, marks a new era in space utility, attracting attention and investment from various quarters, including GiantStepVC.